In people with cardiac sarcoidosis, patterns of signs and symptoms seen when the person is diagnosed can help predict…
Articles by Marisa Wexler, MS
Combining angiotensin receptor blockers or ARBs — a type of medication used to lower blood pressure — with a class…
More than two dozen mutations that seem to increase the risk of developing sarcoidosis were identified in a new…
The findings of a new preclinical study in pulmonary sarcoidosis are lending support to the therapeutic potential of…
The U.S. Food and Drug Administration (FDA) has approved a prefilled syringe version of purified Cortrophin Gel (repository corticotropin injection)Â as…
Roivant Sciences is planning to launch a Phase 2 clinical trial this year to test its experimental oral therapy…
Kinevant Sciences’ experimental therapy namilumab failed to show a benefit for people with chronic, active pulmonary sarcoidosis in…
People with sarcoidosis in the U.S. are more likely than those in the general population to have certain co-occurring…
The lungs are affected in nearly everyone diagnosed with sarcoidosis in the Netherlands, but most patients in the country…
Treatment with Remicade (infliximab) is generally effective for controlling sarcoidosis when it affects the nervous system or liver,…